Literature DB >> 6781010

Effects of chronic amphetamine or reserpine on self-stimulation responding: animal model of depression?

N J Leith, R J Barrett.   

Abstract

The mood-altering properties of amphetamine (AMPH) in humans (euphoria and depression) have been postulated to be related to the increases and decreases respectively which this drug produces in the sensitivity of the reward system of the brain. The present study further evaluated this relationship by testing the effects of chronic reserpine (RES), another treatment that produces depression in humans, on self-stimulation responding. Separate groups of animals implanted with stimulating electrodes in the medial forebrain bundle were administered daily injections of saline, d-AMPH (5 mg/kg X 7 days followed by 10 mg/kg X 7 days), or RES (0.05 mg/kg X 18 days). At treatment termination, both drug groups showed a significant elevation of the reinforcement threshold, with no recovery occurring during 18 subsequent days. Thus, drug-induced depression of self-stimulation responding may serve as an animal model for studying the underlying physiological basis for clinical depression, or at the very least, for drug-induced depression.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6781010     DOI: 10.1007/BF00433801

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  Facilitation of self-stimulation of the prefrontal cortex in rats following chronic administration of spiroperidol or amphetamine.

Authors:  A Robertson; G J Mogenson
Journal:  Psychopharmacology (Berl)       Date:  1979-10       Impact factor: 4.530

2.  SELF-STIMULATION OF THE BRAIN AND THE CENTRAL STIMULANT ACTION OF AMPHETAMINE.

Authors:  L STEIN
Journal:  Fed Proc       Date:  1964 Jul-Aug

3.  Depression and anxiety occurring during Rauwolfia therapy.

Authors:  J C MULLER; W W PRYOR; J E GIBBONS; E S ORGAIN
Journal:  J Am Med Assoc       Date:  1955-10-29

4.  Mental depression in hypertensive patients treated for long periods with large doses of reserpine.

Authors:  E D FREIS
Journal:  N Engl J Med       Date:  1954-12-16       Impact factor: 91.245

5.  Amphetamine and the reward system: evidence for tolerance and post-drug depression.

Authors:  N J Leith; R J Barrett
Journal:  Psychopharmacologia       Date:  1976

6.  Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion.

Authors:  R Watson; E Hartmann; J J Schildkraut
Journal:  Am J Psychiatry       Date:  1972-09       Impact factor: 18.112

7.  Brain biogenic amine depletion and mood.

Authors:  J Mendels; A Frazer
Journal:  Arch Gen Psychiatry       Date:  1974-04

8.  Effects of long-term reserpine treatment on brain tyrosine hydroxylase and behavioral activity.

Authors:  D S Segal; J L Sullivan; R T Kuczenski; A J Mandell
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

9.  Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigm.

Authors:  L Kokkinidis; R M Zacharko
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

10.  Behavioral withdrawal following several psychoactive drugs.

Authors:  D M Simpson; Z Annau
Journal:  Pharmacol Biochem Behav       Date:  1977-07       Impact factor: 3.533

View more
  13 in total

1.  Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.

Authors:  Karen L Skjei; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2003-04-24       Impact factor: 4.530

2.  Self-stimulation and amphetamine: tolerance to d and l isomers and cross tolerance to cocaine and methylphenidate.

Authors:  N J Leith; R J Barrett
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 3.  The validity of animal models of depression.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Brain alpha(2)-adrenoceptors in monoamine-depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNA.

Authors:  C Ribas; A Miralles; X Busquets; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression.

Authors:  Jean-Eric Ghia; Patricia Blennerhassett; Stephen M Collins
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 6.  Cytokine-purine interactions in behavioral depression in rats.

Authors:  Thomas R Minor; Qingjun Huang; Elizabeth A Foley
Journal:  Integr Physiol Behav Sci       Date:  2003 Jul-Sep

7.  Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories.

Authors:  Athina Markou; Paul J Kenny
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

Review 8.  Animal models and treatments for addiction and depression co-morbidity.

Authors:  Neil E Paterson; Athina Markou
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

9.  Effects of Electroacupuncture with Dominant Frequency at SP 6 and ST 36 Based on Meridian Theory on Pain-Depression Dyad in Rats.

Authors:  Yuan-Yuan Wu; Yong-Liang Jiang; Xiao-Fen He; Xiao-Yun Zhao; Xiao-Mei Shao; Jun-Ying Du; Jian-Qiao Fang
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-04       Impact factor: 2.629

Review 10.  Selecting an Appropriate Animal Model of Depression.

Authors:  Yuanzhen Hao; Huixiang Ge; Mengyun Sun; Yun Gao
Journal:  Int J Mol Sci       Date:  2019-09-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.